Covid-19 - Treatment - Medicines - Vaccine- USA, INDIA
Favipiravir ( mild-moderate case ) Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate covid-19. Fabiflu is the first medication to be approved and commercially available for the treatment of covid 19. Favipiravir, sold under the brand name Fabiflu, Avigan or Abigan, is an antiviral medication used to treat influenza in Japan (approved in 2014). But generic name of this medicine is Avifavir. This medicine work for mild to migrate case only it does not work in serious condition of covid-19. The drug is priced at rupees 3500 for a pack of 34 tablets (rupees 103 per tablet). It will be available in retail chemist stores and hospitals coma but it is a prescription drug. It offers rapid reduction in viral load within 4 days and provides faster symptomatic improvement. It has been investigated worldwide, to know how effective it is? Studies from Japan, Russia and China have Shown pos